Neuropsychiatric Disease and Treatment (Jan 2023)
Correlation Between Cognitive Impairment and Homocysteine and S100B Protein in Patients with Progressive Ischemic Stroke
Abstract
Yan Li,1,2 Xiaopeng Chen,1,3 Rujuan Zhou,2 Wu Xu,2 Xiaorong Wang,2 Wa Chao,1 Shouru Xue1 1Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; 2Department of Neurology, The Taixing People’s Hospital, Taixing, People’s Republic of China; 3Department of Neurology, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, People’s Republic of ChinaCorrespondence: Shouru Xue, Department of Neurology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou, 215006, People’s Republic of China, Tel +86-18962133036, Fax +86-512-65223637, Email [email protected]: This study aimed to investigate the relationship between cognitive impairment and homocysteine (Hcy) and S100B protein in patients with progressive ischemic stroke (PIS).Patients and Methods: A total of 158 patients with PIS hospitalized in the Department of Neurology in Taixing People’s Hospital from January 2020 to March 2022 were enrolled in the study. After 90 days of follow-up, the patients were divided into two groups according to the MoCA score— 99 cases with cognitive impairment group (observation group) and 59 cases with cognitive normal group (control group). Causal diagram was drawn to assess the association between risk factors and PIS with observation group. The risk factors indicators of cognitive impairment in patients with PIS were screened. The related predictive indicators were screened by multivariate logistic regression analysis, and Pearson correlation analysis. The predictive value was analyzed by Receiver Operating Characteristic (ROC) curve.Results: Multivariate logistic regression analysis showed that age, hypertension, lesion position, Hcy and S100B protein were related risk factors for cognitive impairment in patients with PIS. Pearson correlation analysis was conducted between Hcy and S100 B protein and MoCA score, and revealed that Hcy and S100 B protein were negatively correlated with MoCA score. ROC curve analysis showed that the Area Under the Curve (AUC) of S100 B protein and Hcy in identifying cognitive impairment after PIS was 0.709 and 0.673, respectively, and the combined AUC of Hcy and S100B protein in predicting cognitive impairment after PIS was 0.739.Conclusion: Hcy and S100B protein are related risk factors for cognitive impairment in patients with PIS, and may be used as in a prediction model to predict cognitive impairment after PIS in the future.Keywords: progressive ischemic stroke, cognitive impairment, homocysteine, S100B protein
